Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2017, Article ID 1365209, 9 pages
https://doi.org/10.1155/2017/1365209
Research Article

Combination Therapy with a Sodium-Glucose Cotransporter 2 Inhibitor and a Dipeptidyl Peptidase-4 Inhibitor Additively Suppresses Macrophage Foam Cell Formation and Atherosclerosis in Diabetic Mice

1Department of Medicine, Division of Diabetes, Metabolism, and Endocrinology, Showa University School of Medicine, Tokyo, Japan
2Department of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden
3Laboratory of Cardiovascular Medicine, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan

Correspondence should be addressed to Tsutomu Hirano; pj.ca.u-awohs.dem@onarih

Received 8 December 2016; Accepted 12 February 2017; Published 19 March 2017

Academic Editor: Maria L. Dufau

Copyright © 2017 Michishige Terasaki et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Michishige Terasaki, Munenori Hiromura, Yusaku Mori, et al., “Combination Therapy with a Sodium-Glucose Cotransporter 2 Inhibitor and a Dipeptidyl Peptidase-4 Inhibitor Additively Suppresses Macrophage Foam Cell Formation and Atherosclerosis in Diabetic Mice,” International Journal of Endocrinology, vol. 2017, Article ID 1365209, 9 pages, 2017. https://doi.org/10.1155/2017/1365209.